Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-09

Clinical Trial Update: Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether vitamin D repletion improves insulin resistance and systemic inflammation; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2020-03-09